PURE - PURE Bioscience, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue7/31/20167/31/20157/31/2014
Total Revenue1,289729550
Cost of Revenue441285344
Gross Profit848444206
Operating Expenses
Research Development9277901,032
Selling General and Administrative6,9787,2948,322
Non Recurring--2,754
Others---
Total Operating Expenses---
Operating Income or Loss-7,057-7,640-11,902
Income from Continuing Operations
Total Other Income/Expenses Net-7,30421862
Earnings Before Interest and Taxes-14,361-7,619-11,767
Interest Expense10810
Income Before Tax-14,371-7,627-11,777
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-14,371-7,627-11,050
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-14,371-7,627-11,050
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-14,371-7,627-11,050